Targets of p56(lck) activity in immature thymoblasts: Stimulation of the Ras/Raf/MAPK pathway

International Immunology

Volumn 9, Issue 2, 1997, Pages 291-306

  Lin, Kui ^a   Abraham, Kristin M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Thymocyte development; Thymocyte transformation; Tyrosine kinases

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CELL VIABILITY; DEVELOPMENT; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE; THYMOCYTE; THYMUS LYMPHOMA;

ANIMALS; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIC AMP; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOMA; MICE; MICE, TRANSGENIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS C-VAV; RAS PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; T-LYMPHOCYTES; THYMUS GLAND; TUMOR CELLS, CULTURED;

EID: 0031051776     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.2.291     Document Type: Article

References (83)

1. Perlmutter, R. M., Levin, S. D., Appleby, M. W., Anderson, S. J. and Alberola-IIa, J. 1993. Regulation of lymphocyte function by protein phosphorylation, Annu. Rev. Immunol. 11:451.
2. Rudd, C. E., Trevillyan, J. N., Wond, L. L., Dasgupta, J. D. and Schlossman, S. F. 1988. The CD4 receptor is complexed to a T-cell specific tyrosine kinase, (pp58) in detergent lysates from human T lymphocytes. Proc. Natl Acad. Sci. USA 85:5190.
3. lck. Cell. 55:301.
4. lck that phosphorylates the CD3 complex. Proc. Natl Acad. Sci. USA 86:3277.
5. lck. Nature 338:257.
6. lck correlates with impaired function in vitro and lack of expression in vivo. Nature 342:278.
7. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511.
8. lck with FcγRIIIA (CD16) in natural killer cells. J. Exp Med. 177:1475.
9. Straus, D. B. and Weiss, A. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585.
10. lck deficiency on the growth and cytolytic effector function of an IL-2-dependent cytotoxic T-cell line. Mol. Cell. Biol. 12:4521.
11. lck: identification of novel intermolecular association. Science 252:1523.
12. lck. Proc. Natl Acad. Sci. USA 88:1996.
13. Perlmutter, R. M., Marth, J. D., Ziegler, S. F., Garvin, A. M., Pawar, S., Cook, M. P. and Abraham, K. M. 1988. Specialized protein tyrosine kinase proto-oncogenes in hematopoietic cells. Biochem. Biophys. Acta 948:245.
14. Bolen, J. B., Thompson, P. A., Eiseman, E. and Horak, I. D. 1991. Expression and interactions of the src family of tyrosine protein kinases in T lymphocytes. Adv. Cancer Res. 57:103.
15. lck. Nature 357:161.
16. lck in thymopoiesis. EMBO J. 4:1671.
17. Mombaerts, P., Clarke, A. R., Hooper, M. L. and Tonegawa, S. 1991. Creation of a large genomic deletion at the T-cell antigen receptor β subunit locus in mouse embryonic stem cells by gene targeting. Proc. Natl Acad. Sci. USA 88:3084.
18. Mombaerts, P., Lacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S. and Papaioannou, V. E. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869.
19. Mombaerts, P., Clarke, A. R., Rudnicki, M. A., Lacomini, J., Itohara, S. S., Lafaille, J. J., Wang, L., Jaenisch, Y., Hooper, M. L. and Tonegawa, S. 1992. Mutations in T-cell antigen receptor genes a and β block thymocyte development at different stages. Nature 360:225.
20. Shinkai, Y., Rathbun, G., Lam, K.-P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charon, J., Datta, M., Young, F., Stall, A. M. and Alt, F. W. 1992 RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:856.
21. lck. J. Exp. Med. 173:1421.
22. lck. EMBO J. 11:4877.
23. Mombaerts, P., Anderson, S. J., Perlmutter, R. M., Mak, T. W. and Tonegawa, S. 1994. An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity 1:261.
24. Shinkai, Y., Koyasu, S., Nakayarna, K.-I., Murphy, K. M., Loh, D. Y., Reinherz, E., L. and Alt, F. W. 1993. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 259:822.
25. Jacobs, H., Vandeputte, D., Tolkamp, L., de Vries, E., Borst, J. and Berns, A. 1994. CD3 components at the surface of pro-T cells can mediate pre-T cell development in vitro. Eur. J. Immunol. 24:934.
26. Levelt, C. N., Ehrfeld, A. and Eichmann, K. 1993. Regulation of thymocyte development through CD3. I. Timepoint of ligation of CD3ε determines clonal deletion or induction of developmental program. J. Exp. Med. 177:707.
27. Levelt, C. N., Mombaerts, P., Iglesias, A., Tonegawa, S. and Eichmann, K. 1993. Restoration of early thymocyte differentiation in T-cell receptor beta-chain-deficient mutant mice by transmembrane signaling through CD3 epsilon. Proc. Natl Acad. Sci. USA 90:11401.
28. -/- mice in the absence of TCR beta chain. Int. Immunol. 6:995.
29. Groettrup, M., Ungewiss, K., Azogui, O., Palacios, R., Owen, M. J., Hayday, A. C. and von Boehmer, H. 1993. A novel disulfide-linked heterodimer on pre-T cells consists of the T cell receptor beta chain and a 33 kd glycoprotein. Cell 75:283.
30. Saint-Ruf, C., Ungewiss, K., Groettrup, M., Bruno, L., Fehling, H. J. and von Boehmer, H. 1994. Analysis and expression of a cloned pre-T cell receptor gene. Science 266:1208.
31. lck Proc. Natl Acad. Sci. USA 88:3977.
32. lck regulates thymocyte development independently of its interaction with CD4 and CD8 co-receptors. J. Exp. Med. 178:245.
33. Rothenberg E. V., Chen, D. and Diamond, R. A. 1993. Functional and phenotypic analysis of thymocytes in SCID mice. J. Immunol. 151:3530.
34. Anderson, S. J. and Perlmutter, R. M. 1995. A signaling pathway governing early thymocyte maturation, Immunol. Today 16:99.
35. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:179.
36. Garvin, A. M., Abraham, K. M., Forbush, K. A., Farr, A. G., Davison, B. L. and Perlmutter, R. M. 1990. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int. Immunol. 2:173.
37. Sambrook, J., Fritsch, E. F. and Maniatis, T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
38. Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R. and Bern, A. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
39. Hedrick, S. M., Nielsen, E. A., Kavaler, J., Cohen, D. I. and Davis, M. M. 1984. Sequence relationships between putative T-cell receptor polypeptides and immuoglobulins. Nature 308:153.
40. Fink, P. J., Matis, L. A., McElligott, D. L., Bookman, M. and Hedrick, S. M. 1986. Correlations between T-cell specificity and the structure of the antigen receptor. Nature 321:219.
41. Feinberg, A. P. and Vogelstein, B. 1983. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.
42. O'Shea, J. J., McVicar, D. W., Bailey, T. L., Burns, C. and Smyth, M. J. 1992. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc, Natl Acad. Sci. USA 89:10306.
43. Wildin, R. S., Garvin, A. M., Pawar, S., Lewis, D. B., Abraham, K. M., Forbush, K. A., Ziegler, S. F., Allen, J. M. and Perlmutter, R. M. 1991. Developmental regulation of lck gene expression in T lymphocytes. J. Exp. Med. 173:383.
44. Casnellie, J. E. and Thom, R. E. 1990. An activating combination of CD2 antibodies stimulates tyrosine phosphorylation in a T lymphocyte cell line. J. Biol. Chem. 261:331.
45. lck). J. Immunol. 142:2430.
46. lck in response to activators of protein kinase C. Oncogene Res. 2:385.
47. ras during T-cell activation and growth. Immunol. Today 16:159.
48. Marth, J. D., Peet, R., Krebs, E. G. and Perlmutter, R. M. 1985. A lymphocyte-specific protein-tyrosine kinase is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell 43:393.
49. Buday, L., Egan, S. E., viciana, P. R., Cantrell, D. A. and Downward, J. 1994. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J. Biol. Chem. 269:9019.
50. Katzav, S., Martin-Zanca, D. and Barbacid, M. 1989. vav, A novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283.
51. Bustelo, X. R. and Barbacid, M. 1992. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256:1196.
52. Gulbins, E., Coggeshall, K M., Baier, G., Katzav, S., Burn, P. and Altman, A. 1993. Tyrosine kinase-stimulated guanine nucleotide exchange activity of vav in T cell activation. Science 260:822.
53. Gupta, S., Weiss, A., Kumar, G., Wang, S. and Nel, A. 1994. The T-cell antigen receptor utilizes LCK, RAF-1 and MEK-1 for activating MAP kinase: evidence for the existence of a second PKC-dependent pathway in an LCK-negative Jurkat cell mutant. J. Biol. Chem. 269:17349.
54. Moodie, S. A., Willumsen, B. M., Weber, M. J. and Wolfman, A. 1993. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase. Science 260:1658.
55. Warne, P. H., Viciana, P. R. and Downward, J. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364:352.
56. v-src are required, but neither is sufficient, to activate the Raf-1 kinase. Proc. Natl Acad. Sci. USA 89:2922.
57. v-ras cooperate in the activation of mitogen-activated protein kinase. Proc. Natl Acad. Sci. USA 90:5772.
58. lck. Science 255:853.
59. fas-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12:4211.
60. Cooke, S. J. and McCormick, F. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069.
61. Graves, L. E., Bornfeldt, K. E., Raines, E. W., Potts, B. C., MacDonald, S. G., Ross, R. and Krebs, E. G. 1993. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl Acad. Sci. USA 90:10300.
62. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J. and Sturgill, T. W. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′5′-cyclic monophosphate. Science 262:1065.
63. ras-mitogen-activated protein kinase pathway in fibroblasts. J. Biol. Chem. 269:3534.
64. Häfner, S., Adler, H. S., Mischak, H., Janosch, P., Heidecker, G., Wolfman, A., Pippig, S., Lohse, M., Ueffing, M. and Kolch, W. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14:6696.
65. Seamon, K. B. and Daly J. W. 1986. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20:1.
66. Peterson, G. 1995. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutrition. 125:784s.
67. Markovits, J., Larsen, A. K., Ségal-Bendirdjian, E., Fossé, P., Saucier, J.-M., Gazit, A., Levitzki, A., Umezawa, K. and Jacquemmin-Sablon, A. 1994. Inhibition of DNA topoisomerase I and II and induction of apoptosis by erbstatin and tyrphostin derivatives. Biochem. Parmacol. 48:549.
68. Traganos, F., Ardelt, B., Halko, N., Bruno, S. and Darzynkiewicz, Z. 1992. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52:6200-6208 .
69. Lepault, F. and Weissman, I. L. 1981. An in vitro assay for thymushoming bone marrow cells. Nature 293:151.
70. Lepault, F., Coffman, R. L. and Weissman, I. L. 1983. Characteristics of thymus-homing bone marrow cells. J. Immunol. 131:64.
71. Bowtell, D., Fu, P., Simon, M. and Senior, P. 1992. Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras. Proc. Natl Acad. Sci. USA 89:6511.
72. McCormick, F. 1993. Signal transduction, How receptors turn Ras on. Nature 363:15.
73. Ravichandran, K. S. and Burakoff, S. J. 1994. The adapter protein She interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J. Biol. Chem. 269:1599.
74. Ravichandran, K. S., Lee, K. K., Songyang, Z., Cantley, L. C., Burn, P. and Burakoff, S. J. 1993. Interaction of She with the ζ chain of the T cell receptor upon T cell activation. Science 262:902.
75. vav activity. Mol. Cell. Biol. 15:4337.
76. Katzav, S., Cleveland, J. L., Heslop, H. E. and Pulido, D. 1991. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11:1912.
77. Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J. and Crabtree, G. R. 1992. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358:70.
78. Perkins, G. R., Marvel, J. and Collins, M. K. 1993. Interleukin 2 activates extracellular signal-regulated protein kinase 2. J. Exp. Med. 178:1429.
79. Ward, Y., Gupta, S., Jensen, R., Wartmann, M., Davis, R. J. and Kelly, K. 1994. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 367:651.
80. csk. Nature 365:156.
81. Lingk, D. S., Chan, M. A. and Gelfand, E. W. 1990. Increased cyclic adenosine monophosphate levels block progression by not initiation of human T cell proliferation. J. Immunol. 145:449.
82. Li, S. and Sedivy, J. 1993. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc. Natl Acad. Sci. USA 90:9247.
83. Monfar, M., Lemon, K. P., Grammer, T. C., Cheatham, L., Chung, J., Vlahos, C. J. and Blenis, J. 1995. Activation of pp70/85 S6 kinase in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15:326.